跳至主要内容
临床试验/NCT07840560
NCT07840560尚未招募不适用

Comparing Two Multicomponent ICU Bundles To Promote Sleep and Reduce Delirium in Critically Ill Adults

University of California, San Diego8 个研究点 分布在 2 个国家目标入组 62,500 人开始时间: 2026年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
62,500
试验地点
8
主要终点
Delirium incidence

研究概览

简要总结

SHANTI-ICU compares the effectiveness of two evidence-based multicomponent ICU sleep promotion bundles on delirium and patient-reported sleep quality in critically ill adults.

Bundle A is a non-pharmacologic strategy. Bundle B includes all components of Bundle A plus pharmacist-led pharmacologic strategies. Sixteen intensive care units across eight hospitals implement one of the two bundles as a unit-level change to routine care, using a concurrent multiple-intervention stepped wedge randomized design.

The primary outcome is delirium incidence, measured using the Confusion Assessment Method for the ICU (CAM-ICU) as documented during routine clinical care. Secondary outcomes are delirium duration, ICU length of stay, nightly patient-reported sleep quality, and overall patient-reported ICU sleep quality.

Patients receive the assigned bundle as part of routine care. The study operates under an IRB-approved waiver of informed consent and waiver of HIPAA authorization; there is no individual enrollment procedure.

详细描述

DESIGN SHANTI-ICU is a pragmatic, hybrid type I effectiveness-implementation study using a concurrent multiple-intervention stepped wedge randomized design. The unit of randomization is the hospital, not the individual patient. Eight hospitals, i.e. "clusters" with two ICUs per hospital, will be randomized to Bundle A or Bundle B, and to the time at which they cross over from usual care.

All clusters begin in a usual care preparation period consisting of 9 to 18 months, cross over in one of 4 steps with 3 months between each step, and remain in the implementation period consisting of 24 to 33 months. An evaluation phase follows implementation.

SETTING AND POPULATION Participating hospitals span academic, community, safety-net, and resource-limited settings. Based on historical census at the participating hospitals, approximately 62,500 adult ICU admissions are anticipated across the preparation and implementation phases.

INTERVENTIONS Bundle A is an evidence-based, multicomponent, non-pharmacologic sleep promotion strategy. Bundle A includes reducing nighttime noise and light, clustering patient care interactions, offering non-pharmacologic sleep aids such as earplugs and eye masks, and promoting daytime wakefulness through light exposure and out-of-bed activity.

Bundle B includes Bundle A plus pharmacist-led pharmacologic strategies. These include deprescribing medications known to disrupt sleep, optimizing the timing of medication administration, and selective use of sleep-promoting agents (e.g., melatonin, dexmedetomidine).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 years or older
  • •Present in participating ICU

排除标准

  • •Age less than 18 years
  • •Present in ICU less than 1 night

研究组 & 干预措施

Usual Care

No Intervention

Period prior to cluster crossover. Hospitals/ICUs deliver usual care without a structured sleep promotion bundle. Delirium and sleep outcomes are collected in the same way during this period as during implementation.

Bundle A

Active Comparator

Multicomponent non-pharmacologic ICU sleep promotion bundle delivered as a unit-level change to routine care.

干预措施: Nighttime noise & light reduction (Behavioral)

Bundle A

Active Comparator

Multicomponent non-pharmacologic ICU sleep promotion bundle delivered as a unit-level change to routine care.

干预措施: Clustering patient-care interactions (Behavioral)

Bundle A

Active Comparator

Multicomponent non-pharmacologic ICU sleep promotion bundle delivered as a unit-level change to routine care.

干预措施: Non-pharmacologic sleep aids (Behavioral)

Bundle A

Active Comparator

Multicomponent non-pharmacologic ICU sleep promotion bundle delivered as a unit-level change to routine care.

干预措施: Daytime light exposure (Behavioral)

Bundle A

Active Comparator

Multicomponent non-pharmacologic ICU sleep promotion bundle delivered as a unit-level change to routine care.

干预措施: Encourage out-of-bed activity (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Nighttime noise & light reduction (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Clustering patient-care interactions (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Non-pharmacologic sleep aids (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Daytime light exposure (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Encourage out-of-bed activity (Behavioral)

Bundle B

Active Comparator

All components of Bundle A plus pharmacist-led pharmacologic sleep promotion strategies, delivered as a unit-level change to routine care.

干预措施: Medication management to support nighttime sleep (Other)

结局指标

主要结局

Delirium incidence

时间窗: From ICU admission until first positive CAM-ICU, ICU discharge, or death, whichever comes first, an expected average of 5 days

Indicator that a patient screens positive on the Confusion Assessment Method for the ICU (CAM-ICU) at any point during their ICU stay. CAM-ICU is performed by ICU nursing staff as part of usual clinical care and abstracted from the health record.

次要结局

  • Delirium duration (delirium/coma-free days)(From ICU admission through ICU day 7, ICU discharge, or death, whichever comes first)
  • ICU sleep quality (Richards-Campbell Sleep Questionnaire)(Collected up to 7 times per week in the morning (rating the prior night's sleep), from ICU day 2 through ICU discharge or death, an expected average of 5 days)
  • Overall ICU sleep quality (Sleep in the ICU Questionnaire)(Once, within 48 hours after ICU discharge and before hospital discharge, an expected average of 10 days after ICU admission)
  • ICU Length of Stay(From the time of ICU admission to the time of ICU discharge or death, an expected average of 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Biren Kamdar

Principal Investigator

University of California, San Diego

研究点 (8)

Loading locations...

相似试验